News & analysis on the clinical development and manufacture of large molecule drugs
Top five stories from October
By Jane Byrne
- Last updated on
COVID-19 is like a big oak tree casting shade on all other biopharma industry developments. Vaccine-related articles dominate the most popular story rankings. With Pfizer and BioNTech now out front in the coronavirus vaccine race, we track the related news from them and their rivals that resonated with you last month.